Parathyroid Carcinoma: Evaluation and Interdisciplinary Management

Cancer

Volumn 100, Issue 5, 2004, Pages 900-905

  Clayman, Gary L ^a   Gonzalez, Hernan E ^b   El Naggar, Adel ^a   Vassilopoulou Sellin, Rena ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adjuvant radiation therapy; Comprehensive surgical excision; Head and neck; Parathyroid carcinoma

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DIURETIC AGENT; GALLIUM; INFUSION FLUID; MITHRAMYCIN;

ADULT; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; EVALUATION; EXPERIENCE; FEMALE; HUMAN; HYPERCALCEMIA; ONCOGENE; PARATHYROID CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; STANDARDIZATION; SURVIVAL RATE;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1242336806     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20089     Document Type: Review

References (26)

1. Pyrah LN, Hodgkinson A, Anderson CK. Primary hyperparathyroidism. Br J Surg. 1966;53:295-316.
2. Shantz A, Castelman B. Parathyroid carcinoma. A study of 70 cases. Cancer. 1973;31:600-605.
3. Hakaim AG, Powsner R, Cho SI. Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation. Cleveland Clin J Med. 1993;60:331-335.
4. Shane E. Parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86:485-493.
5. de Quevain F. Parastruma maligna aberrata. Deutsche Zeitschrift Fuer Chirurgie. 1904;100:334-352.
6. Sainton P, Millot J. Malegne dún adenoma parathyroidiene eosinophile; au cours dune de Recklinghausen. Annales Anatomie Pathologique. 1933;10:813.
7. Busaidy N, Jimenez C, Habra MA, et al. Two decades of experience with parathyroid carcinoma. Proc Am Soc Clin Oncol. 2003;22:516.
8. Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol. 1999;8:155-165.
9. Cohn K, Silverman M, Corrado J, Sedgewick C. Parathyroid carcinoma: the Lahey Clinic experience. Surgery. 1985;98: 1095-1100.
10. Favia G, Lumachi F, Polistina F, D'Amico DF. Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg. 1998;22:1225-1230.
11. Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol. 1993;17:820-829.
12. Cryns VL, Thor A, Xu HJ. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med. 1994;330:757-761.
13. Pearce SH, Trump D, Wooding C, Sheppard MN, Clayton RN, Thakker RV. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumors. Clin Endocrinol (Oxford). 1996;45:195-200.
14. Yoshimoto K, Endo H, Tsuyuguchi M, et al. Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features. Clin Endocrinol (Oxford). 1998;48:67-72.
15. Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A. p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab. 1994;78:1320-1324.
16. Subramaniam P, Wilkinson S, Shepherd JJ. Inactivation of retinoblastoma gene in malignant parathyroid growths: a candidate genetic trigger? Aust NZ J Surg. 1995;65:714-716.
17. Shattuck TM, Valimaki S, Obara T, et al. Somatic and germ line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003;349:1722-1729.
18. Carpten JD, Robbins CM, Villablanca A. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32:676-680.
19. Howell VM, Haven CJ, Kahnoski K. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet. 2003;40:657-663.
20. Hsi ED, Zukerberg LR, Yang WI, Arnold A. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. Diagn Mol Pathol. 1996;5: 220-224.
21. Vasef MA, Brynes RK, Sturm M, Bromley C, Robinson RA. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol. 1999;12:412-416.
22. Collins MT, Skarulis MC, Bilezikian JP, et al. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab. 1998;83: 1083-1088.
23. Hundahl SA, Fleming ID, Fremgen AM, et al. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Database report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999; 86:538-544.
24. Chow E, Tsang RW, Brierley JD, et al. Parathyroid carcinoma - the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1998;41:569-572.
25. Obara T, Fujimoto Y. Diagnosis and treatment of patients with parathyroid carcinoma: an update and review. World J Surg. 1991;15:738-744.
26. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, et al. Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery. 1983;94:906-915.